LEP and breast carcinoma: An epidemiologic review of preclinical and clinical investigations on the roles of obesity in recurrence and death from breast cancer highlights clinical investigations on serum levels of leptin as a potential biomarker for primary or secondary outcome measures in breast cancer patients after behavioral dietary and exercise interventions [271].